Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction

(2013) Zubin J. Eapen et al.   AMERICAN HEART JOURNAL

Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

(2013) Amil M. Shah et al.   Circulation-Heart Failure

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction

(2013) David D. McManus et al.   Journal of the American Heart Association

Baseline Characteristics of Patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

(2012) Sanjiv J. Shah et al.   Circulation-Heart Failure

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

(2011) Akshay S. Desai et al.   AMERICAN HEART JOURNAL

Atrial Fibrillation Pathophysiology

(2011) Yu-ki Iwasaki et al.   CIRCULATION

Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study

(2011) Michael A. Rosenberg et al.   EUROPEAN HEART JOURNAL